HU9603237D0 - Kristalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane - Google Patents

Kristalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane

Info

Publication number
HU9603237D0
HU9603237D0 HU9603237A HUP9603237A HU9603237D0 HU 9603237 D0 HU9603237 D0 HU 9603237D0 HU 9603237 A HU9603237 A HU 9603237A HU P9603237 A HUP9603237 A HU P9603237A HU 9603237 D0 HU9603237 D0 HU 9603237D0
Authority
HU
Hungary
Prior art keywords
dioxydo
benzisothiazo
kristalline
chromane
dihydro
Prior art date
Application number
HU9603237A
Other languages
English (en)
Inventor
Oliver Brehm
Michael Conrad
Alfons Grunenberg
Dietrich Seidel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HU9603237D0 publication Critical patent/HU9603237D0/hu
Publication of HUP9603237A2 publication Critical patent/HUP9603237A2/hu
Publication of HUP9603237A3 publication Critical patent/HUP9603237A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
HU9603237A 1995-11-22 1996-11-22 Crystalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane, process for the preparation thereof and pharmaceutical compositions containing them HUP9603237A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19543478A DE19543478A1 (de) 1995-11-22 1995-11-22 Kristallines Hydrochlorid von {(R)-(-)-2- N-[4-(1,1-Dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl)-buytl]-aminomethyl}-chroman

Publications (3)

Publication Number Publication Date
HU9603237D0 true HU9603237D0 (en) 1997-01-28
HUP9603237A2 HUP9603237A2 (hu) 1998-01-28
HUP9603237A3 HUP9603237A3 (en) 1998-12-28

Family

ID=7778081

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9603237A HUP9603237A3 (en) 1995-11-22 1996-11-22 Crystalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane, process for the preparation thereof and pharmaceutical compositions containing them

Country Status (32)

Country Link
US (1) US5830908A (hu)
EP (1) EP0775704B1 (hu)
JP (1) JPH09143180A (hu)
KR (1) KR970027079A (hu)
CN (1) CN1086703C (hu)
AR (1) AR004961A1 (hu)
AT (1) ATE201872T1 (hu)
AU (1) AU712922B2 (hu)
BR (1) BR9605646A (hu)
CA (1) CA2190700A1 (hu)
CZ (1) CZ289730B6 (hu)
DE (2) DE19543478A1 (hu)
DK (1) DK0775704T3 (hu)
EE (1) EE9600183A (hu)
ES (1) ES2159342T3 (hu)
GR (1) GR3036505T3 (hu)
HU (1) HUP9603237A3 (hu)
IL (1) IL119647A (hu)
MX (1) MX9605741A (hu)
MY (1) MY132473A (hu)
NO (1) NO307340B1 (hu)
NZ (1) NZ299780A (hu)
PL (1) PL317090A1 (hu)
PT (1) PT775704E (hu)
RU (1) RU2181723C2 (hu)
SG (1) SG44989A1 (hu)
SI (1) SI0775704T1 (hu)
SK (1) SK150096A3 (hu)
TR (1) TR199600930A2 (hu)
TW (1) TW449595B (hu)
UA (1) UA45338C2 (hu)
ZA (1) ZA969753B (hu)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854217A (en) * 1992-09-28 1998-12-29 Bearsden Bio, Inc. Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
EA030606B1 (ru) 2006-05-04 2018-08-31 Бёрингер Ингельхайм Интернациональ Гмбх Способы приготовления лекарственного средства, содержащего полиморфы
KR101610005B1 (ko) * 2007-08-17 2016-04-08 베링거 인겔하임 인터내셔날 게엠베하 Ｆａｂ 관련 질환의 치료에 사용하기 위한 푸린 유도체
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
EA031225B1 (ru) * 2008-08-15 2018-12-28 Бёрингер Ингельхайм Интернациональ Гмбх Ингибиторы дпп-4 для заживления ран
EP2344195A2 (en) 2008-09-10 2011-07-20 Boehringer Ingelheim International GmbH Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
BRPI0923121A2 (pt) 2008-12-23 2015-08-11 Boehringer Ingelheim Int Formas salinas de compostos orgânico
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
ES2760917T3 (es) 2009-11-27 2020-05-18 Boehringer Ingelheim Int Tratamiento de pacientes diabéticos genotipificados con inhibidores DPP-IV como la linagliptina
JP6034781B2 (ja) 2010-05-05 2016-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 併用療法
EA201991014A1 (ru) 2010-06-24 2019-09-30 Бёрингер Ингельхайм Интернациональ Гмбх Лечение диабета
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
MX366629B (es) 2011-07-15 2019-07-17 Boehringer Ingelheim Int Quinazolinas sustituidas, su preparación y su uso en composiciones farmacéuticas.
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
JP2019517542A (ja) 2016-06-10 2019-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング リナグリプチンおよびメトホルミンの組合せ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901814A1 (de) 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
US5300523A (en) * 1988-07-28 1994-04-05 Bayer Aktiengesellschaft Substituted aminomethyltetralins and their heterocyclic analogues
DE4138756A1 (de) * 1991-11-26 1993-05-27 Troponwerke Gmbh & Co Kg Kombination mit neuroprotektiver wirkung

Also Published As

Publication number Publication date
TW449595B (en) 2001-08-11
MY132473A (en) 2007-10-31
CN1086703C (zh) 2002-06-26
NZ299780A (en) 1998-09-24
UA45338C2 (uk) 2002-04-15
MX9605741A (es) 1997-05-31
ATE201872T1 (de) 2001-06-15
NO307340B1 (no) 2000-03-20
AR004961A1 (es) 1999-04-07
PT775704E (pt) 2001-09-28
DK0775704T3 (da) 2001-07-23
NO964950L (no) 1997-05-23
SI0775704T1 (en) 2001-08-31
DE59607040D1 (de) 2001-07-12
CZ342896A3 (en) 1997-06-11
EP0775704B1 (de) 2001-06-06
EE9600183A (et) 1997-06-16
IL119647A (en) 1999-12-22
AU7177296A (en) 1997-05-29
KR970027079A (ko) 1997-06-24
ZA969753B (en) 1997-03-25
CZ289730B6 (cs) 2002-03-13
PL317090A1 (en) 1997-05-26
BR9605646A (pt) 1998-08-18
CA2190700A1 (en) 1997-05-23
GR3036505T3 (en) 2001-11-30
AU712922B2 (en) 1999-11-18
CN1152574A (zh) 1997-06-25
DE19543478A1 (de) 1997-05-28
NO964950D0 (no) 1996-11-21
US5830908A (en) 1998-11-03
EP0775704A1 (de) 1997-05-28
HUP9603237A2 (hu) 1998-01-28
RU2181723C2 (ru) 2002-04-27
ES2159342T3 (es) 2001-10-01
IL119647A0 (en) 1997-02-18
HUP9603237A3 (en) 1998-12-28
JPH09143180A (ja) 1997-06-03
TR199600930A2 (tr) 1997-06-21
SK150096A3 (en) 1997-08-06
SG44989A1 (en) 1997-12-19

Similar Documents

Publication Publication Date Title
HU9603237D0 (en) Kristalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane
AU4786496A (en) New forms of paroxetin hydrochloride
PL300235A1 (en) 5-{2-[4-(1,2-benzoisothiazolyl-3)-1-piperozinyl] ethyl}-6-chloro-1,3-dihydro-2h-indolone-2 hydrochloride monohydrate
PL327406A1 (en) 1-(1,2-disubstituted-piperidinyl)-4-substituted derivatives of piperazine
NO965084D0 (no) N-[3(3-cyanopyrazol[1,5-aÅpyrimidin-7-yl)fenylÅ-N-etyl-acetamid
PL331900A1 (en) 1,4-heterocyclic inhibitors of metaloprotease
HU9601475D0 (en) Substituted n-(indolo-2-carbonyl)-glycinamides and derivatives as antidiabetic agents
PL331838A1 (en) 1,3-diheterocyclic inhibitors of metaloproteases
NO972679L (no) Fremgangsmåte for fremstilling av 1-(2'-deoksy-2',2'-difluor-D-ribofuranosyl-4-aminopyrimidin-2-on)hydroklorid
PL333945A1 (en) Herbicides containing n-[(4,6-dimethosypyrimidin-2-yl)amicocarbonyl]-5-methylsulphonamidemethylo-2-alkoxycarbonylbenzene sulphonamides
PL326498A1 (en) D-winian(-)cis-6(s)-phenyl-5(r)-[4-(pyrolydin-1-ylethoxy)phenyl]5,6,7,8-tetrahydronaphtalen-2-ol
PL334184A1 (en) Fungicidal compositions based on methyl n-(phenylacetyl)-n-(2,6-xylyl) alaninate
EP0754407A3 (en) Liquid compositions of 1,2-benzisothiazolin-3-one
ZA965922B (en) Preparation of N-substituted 3-hydroxypyrazoles.
PL319163A1 (en) Inhibitors of 5 alpha-reductase
HUP0000934A3 (en) 4-{2-[n-(3-phenoxy-2-hydroxy)propylamino]-ethyl}-anilide derivatives and pharmaceutical compositions thereof
EP0828493A4 (en) 4.4-DISUBSTITUTED CYCLOHEXANE-1-OL MONOMERS AND RELATED COMPOUNDS
FI974002A (fi) Menetelmä ranitidiinihydrokloridi 1 muodon valmistamiseksi
IL120343A0 (en) Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-YL)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
AP9600854A0 (en) Polymorphs of the pro drug 6 N-(L-ALA-L-ALA) - trovafloxacin
HUP9802546A3 (en) 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen-1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof
ITMI950540A0 (it) Procedimento per la preparazione di 4 (nitrofenil) diidropiridine
AU1251399A (en) N-alkylation of 5-amino-2,4,6-triiodo-isophthalamides
AU1479800A (en) Procedure for synthesis of N-(2(((5-((dialkilamino) methyl)-2- furanyl) methyl)thyo) ethyl)-N'- alkyl-2-nitro1,1 alkenediamines and their hydrochlorides
HUP9600316A2 (en) Process for the preparation of n-(ortho-alkyl-phenyl)-imides